Literature DB >> 5513630

[Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II].

G Gauthier, J de Ajuriaguerra, B Simona, J Constantinidis, J J Eisenring, M Krassoievitch, G Yanniotis, R Tissot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5513630

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN： 0035-3787            Impact factor:   2.607


× No keyword cloud information.
  6 in total

1.  Brocresine in Parkinson's disease. Action of a peripheral and central decarboxylase inhibitor in potentiating levodopa.

Authors:  P M Howse; W B Matthews
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-02       Impact factor: 10.154

2.  Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors:  U K Rinne; V Sonninen; T Sirtola
Journal:  Z Neurol       Date:  1972

3.  Parkinson's disease and striatal dopamine: in vivo morphological evidence for the presence of dopamine in the human brain.

Authors:  J Constantinidis; J Siegfried; T L Frigyesi; R Tissot
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

4.  [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].

Authors:  E Schneider; P A Fischer; P Jacobi; H Maxion
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1973-03-19

Review 5.  The pharmacology of Parkinson's disease: basic aspects and recent advances.

Authors:  M Da Prada; H H Keller; L Pieri; R Kettler; W E Haefely
Journal:  Experientia       Date:  1984-11-15

6.  Levodopa combined with peripheral decarboxylase inhibition in Parkinson's disease.

Authors:  A Barbeau; H Mars; M I Botez; M Joubert
Journal:  Can Med Assoc J       Date:  1972-06-10       Impact factor: 8.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.